Plasmacytoma — Trials

Plasmacytoma — Trials · CancerIndex

Clinical trials

Registered studies

28 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 6
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Memorial Sloan Kettering Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03031730	Testing the Addition of KRT-232 (AMG 232) to Usual Chemotherapy for Relapsed Multiple Myeloma	terminated	Phase 1	35	National Cancer Institute (NCI)NIH	1	Feb 10, 2026	clinicaltrials
NCT03312868	Stereotactic Body Radiotherapy for the Treatment of Solitary Bone Plasmacytoma	terminated	Phase 2	10	Instituto do Cancer do Estado de São PauloOTHER	1	Apr 6, 2022	clinicaltrials